Clinical Trial: Evaluation of the Atlas Genetics io® CTNG System
Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Observational
Official Title: IO-CTNG: A Multi-Centre Evaluation of the Atlas Genetics io® CTNG System Used in Centralised and Point of Care Settings
Brief Summary: The objective of the study is to compare Atlas Genetics io® system results with those obtained from comparator devices.
Detailed Summary:
Sponsor: Atlas Genetics Limited
Current Primary Outcome: Diagnostic Accuracy compared to positive Composite Infected Status from comparator devices [ Time Frame: Up to 7 days ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Atlas Genetics Limited
Dates:
Date Received: February 27, 2017
Date Started: May 18, 2017
Date Completion: January 2018
Last Updated: May 18, 2017
Last Verified: May 2017